MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • 2023 International Congress

    MRI morphometry and regional hypometabolism in the clinical predominance-types of Progressive Supranuclear Palsy

    H. Chovatiya, K. Pillai, R. Kamble, S. Santhamma, P. Rajeswari, M. Chacko, A. Kishore (Kochi, India)

    Objective: To compare brain MRI morphometry and regional hypometabolism among the clinical predominance-types of Progressive Supranuclear Palsy. Background: Recently, MDS-PSP criteria for the clinical diagnosis…
  • 2023 International Congress

    Asymmetric synaptic density and glucose consumption in subjects with non-demented Parkinson’s Disease, as measured with [11C]UCB-J and [18F]FDG PET.

    K. Andersen, A. Hansen, J. Horsager, K. Knudsen, P. Borghammer (Aarhus, Denmark)

    Objective: The objective of this study was to investigate asymmetric synaptic density and glucose consumption in moderate-stage non demented PD patients and the association between…
  • 2023 International Congress

    Association of Increased Frontal White Matter A2A Receptor Availability with Decreased Frontal Gray Matter Volume in Patients with Parkinson’s Disease

    I. Waggan, E. Rissanen, J. Tuisku, M. Matilainen, R. Parkkola, J. Rinne, L. Airas (Turku, Finland)

    Objective: We sought to investigate in vivo changes in A2A receptor availability in cerebral white matter of PD patients and its association with gray matter…
  • 2022 International Congress

    In vivo synaptic density in parkinsonism

    C. Uribe, KL. Desmond, R. Raymond, K. Smart, A. Reilhac, A. Mena, AE. Lang, G. Kovacs, N. Vasdev, AP. Strafella (Toronto, Canada)

    Objective: To provide first evidence of in vivo binding properties of the [18F]SynVesT-1 tracer (aka [18F]-SDM-8) for the quantification of synaptic density loss in a…
  • 2022 International Congress

    Brain effects of high-intensity exercise on the dopamine system in individuals with Parkinson’s disease

    S. Tinaz, B. de Laat, G. Stanley, J. Hoye, J. Key, M. Hespeler, J. Ligi, Y. Huang, N. Nabulsi, E. Morris (New Haven, USA)

    Objective: We used PET imaging with 18F-FE-PE2I to quantify dopamine transporter availability and neuromelanin (NM)-MRI to measure the NM content in the substantia nigra (SN)…
  • 2022 International Congress

    Longitudinal combined 11C UCB J and 18F FE PE2I PET imaging of presynaptic terminal loss in early Parkinson’s disease.

    A. Delva, K. van Laere, W. Vandenberghe (Leuven, Belgium)

    Objective: To longitudinally assess presynaptic terminal loss in vivo over a 2-year period in people with early Parkinson’s disease (PD). Background: Imaging tools that allow…
  • 2022 International Congress

    Distinct amyloid-dependent patterns of nigral dopamine depletion in Lewy body diseases

    K. Baik, J. Cha, M. Park, Y. Lee, SW. Kang, SH. Yoon, H. Na, Y. Sohn, P. Lee (Seoul, Republic of Korea)

    Objective: To investigate the effect of amyloid on striatal 18F-FP-CIT uptake patterns in Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy…
  • 2022 International Congress

    FDG-PET features of Lewy body dementia among patients with amnestic presentations typical for Alzheimer’s disease

    J. Silva-Rodríguez, MA. Labrador-Espinosa, A. Moscoso, M. Schöll, P. Mir, M. Grothe (Sevilla, Spain)

    Objective: To better understand the role of FDG-PET for identifying dementia with Lewy bodies (DLB) in the context of Alzheimer’s disease (AD)-like amnestic presentations, we…
  • 2022 International Congress

    Multimodal assessment of nigrostriatal degeneration in de novo Parkinson’s disease

    M. López-Aguirre, M. Matarazzo, J. Blesa, A. Sánchez-Ferro, M. Hm Monje, J. Obeso, J. Pineda-Pardo (Móstoles, Spain)

    Objective: To study nigrostriatal changes with a multifactorial neuroimaging approach in order to further characterize early abnormalities in Parkinson’s Disease (PD). Background: Imaging techniques allow…
  • 2022 International Congress

    Effect of exercise on brain metabolism and energetics in PD

    C. Bevington, R. Jayde Williams, B. Pike, J. Mckenzie, J. Zhang, W. Luh, AJ. Stoessl, V. Sossi (Vancouver, Canada)

    Objective: To identity the effect of exercise on brain metabolism and energetics in PD using PET/MR imaging. Background: Aerobic exercise slows PD progression as reflected…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley